-+ 0.00%
-+ 0.00%
-+ 0.00%
Takeda's skin disease drug trial shows efficacy, more than 2.5 times that of competitor drugs after 16 weeks of administration.
Share

Please log in to view news

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending